Show simple item record

dc.contributor.authorBerlin, Joshua
dc.contributor.authorKatz, Kenneth H.
dc.contributor.authorHelm, Klaus F.
dc.contributor.authorMaloney, Mary E.
dc.date2022-08-11T08:08:17.000
dc.date.accessioned2022-08-23T15:49:11Z
dc.date.available2022-08-23T15:49:11Z
dc.date.issued2002-04-01
dc.date.submitted2014-06-02
dc.identifier.citation<p>Berlin J, Katz KH, Helm KF, Maloney ME. The significance of tumor persistence after incomplete excision of basal cell carcinoma. J Am Acad Dermatol. 2002 Apr;46(4):549-53. doi:10.1067/mjd.2002.117733</p>
dc.identifier.issn0190-9622 (Linking)
dc.identifier.doi10.1067/mjd.2002.117733
dc.identifier.pmid11907506
dc.identifier.urihttp://hdl.handle.net/20.500.14038/28370
dc.description.abstractBACKGROUND: Physicians inevitably receive a pathology report after excision of a basal cell carcinoma that indicates that it is incompletely excised. The physician and patient are then left with the dilemma of whether immediate re-excision or close clinical follow-up is indicated. OBJECTIVE: Our purpose was to identify characteristics of incompletely excised basal cell carcinomas that are at low risk for recurrence. METHODS: We retrospectively reviewed the charts and pathology slides of all incompletely excised basal cell carcinomas from 1991 to 1994 in a university hospital tumor registry. RESULTS: Incompletely excised basal cell carcinomas of superficial or nodular subtype, less than 1 cm in diameter, located anywhere except the nose or ears, with less than 4% marginal involvement on the initial inadequate excision had no evidence of tumor persistence. CONCLUSION: When physicians receive a pathology report indicating the incomplete excision of a basal cell carcinoma, they face the dilemma of further management. The majority of patients should undergo immediate re-excision or Mohs micrographic surgery because tumor persistence was found in 28% of cases. Occasionally, for a small group of select patients, close clinical follow-up may be indicated if the risk of recurrence is very low.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=11907506&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1067/mjd.2002.117733
dc.subjectCarcinoma, Basal Cell
dc.subjectHumans
dc.subjectNeoplasm Recurrence, Local
dc.subjectNeoplasm, Residual
dc.subjectReoperation
dc.subjectRetrospective Studies
dc.subjectRisk Factors
dc.subjectSkin Neoplasms
dc.subjectDermatology
dc.subjectNeoplasms
dc.subjectSkin and Connective Tissue Diseases
dc.titleThe significance of tumor persistence after incomplete excision of basal cell carcinoma
dc.typeJournal Article
dc.source.journaltitleJournal of the American Academy of Dermatology
dc.source.volume46
dc.source.issue4
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/derm_pubs/21
dc.identifier.contextkey5639545
html.description.abstract<p>BACKGROUND: Physicians inevitably receive a pathology report after excision of a basal cell carcinoma that indicates that it is incompletely excised. The physician and patient are then left with the dilemma of whether immediate re-excision or close clinical follow-up is indicated.</p> <p>OBJECTIVE: Our purpose was to identify characteristics of incompletely excised basal cell carcinomas that are at low risk for recurrence.</p> <p>METHODS: We retrospectively reviewed the charts and pathology slides of all incompletely excised basal cell carcinomas from 1991 to 1994 in a university hospital tumor registry.</p> <p>RESULTS: Incompletely excised basal cell carcinomas of superficial or nodular subtype, less than 1 cm in diameter, located anywhere except the nose or ears, with less than 4% marginal involvement on the initial inadequate excision had no evidence of tumor persistence.</p> <p>CONCLUSION: When physicians receive a pathology report indicating the incomplete excision of a basal cell carcinoma, they face the dilemma of further management. The majority of patients should undergo immediate re-excision or Mohs micrographic surgery because tumor persistence was found in 28% of cases. Occasionally, for a small group of select patients, close clinical follow-up may be indicated if the risk of recurrence is very low.</p>
dc.identifier.submissionpathderm_pubs/21
dc.contributor.departmentDepartment of Medicine, Division of Dermatology
dc.source.pages549-53


This item appears in the following Collection(s)

Show simple item record